Latest filing published 03 Jul 2024 for Recursion Pharmaceuticals, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Terry-Ann Burrell span 2 companies, the busiest being Recursion Pharmaceuticals, Inc. and Beam Therapeutics Inc. Over a trading history stretching from 28 June 2021 to 1 July 2024, the count stands at 24 filings.
Sales make up the whole of the open-market record (3 sales, €476k). The rest of the record consists of 16 share grants and 5 option exercises. So far in 2024, the count stands at no purchases and 1 sale.
The record was last updated on 3 July 2024 with a share grant in Recursion Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations